FOXA1 is an independent prognostic marker for ER-positive breast cancer

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

(2010) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

FOXA1 is a key determinant of estrogen receptor function and endocrine response

(2010) Antoni Hurtado et al.   NATURE GENETICS

Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers

(2009) J. Eeckhoute et al.   GENOME RESEARCH

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores

(2009) Foluso O Ademuyiwa et al.   MODERN PATHOLOGY

GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value

(2008) D. Voduc et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance

(2008) Hany Onsy Habashy et al.   EUROPEAN JOURNAL OF CANCER

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications

(2008) S Badve et al.   JOURNAL OF CLINICAL PATHOLOGY

Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients

(2008) Michelle P. Wong et al.   PATHOLOGY

FoxA1 as a lineage-specific oncogene in luminal type breast cancer

(2007) Noritaka Yamaguchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS